Peroxisome Proliferator-Activated Receptor Gamma Pro12Ala/C161T Genotypes and Risky Haplotype Altering Risk of Breast Cancer: A Turkish Case–Control Study

dc.contributor.author	Unal, E.
dc.contributor.author	Aslan, E.I.
dc.contributor.author	Ozturk, T.
dc.contributor.author	Kurnaz, Gomleksiz, O.
dc.contributor.author	Kucukhuseyin, O.
dc.contributor.author	Tuzuner, M.B.
dc.contributor.author	Seyhan, M.F.
dc.contributor.author	Ozturk, O.
dc.contributor.author	Yilmaz, Aydogan, H.
dc.date.accessioned	2021-12-21T08:40:28Z
dc.date.available	2021-12-21T08:40:28Z
dc.date.issued	2021
dc.identifier.issn	62928
dc.identifier.uri	https://doi.org/10.1007/s10528-021-10068-5
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1000
dc.description.abstract	Breast cancer (BC) has a high incidence rate among women worldwide, and the mechanisms and etiology of this disease are not yet fully understood. The peroxisome proliferator-activated receptor gamma (PPARgamma), a nuclear hormone receptor that plays impor
dc.description.sponsorship	The present study was supported by a grant from the Scientific Research Projects Coordination Unit of Istanbul University (Project No:24082).
dc.language.iso	English
dc.publisher	Springer
dc.title	Peroxisome Proliferator-Activated Receptor Gamma Pro12Ala/C161T Genotypes and Risky Haplotype Altering Risk of Breast Cancer: A Turkish Case–Control Study
dc.type	Article
dc.relation.journal	Biochemical Genetics
dc.identifier.issue	6
dc.identifier.startpage	1413
dc.identifier.endpage	1426
dc.identifier.volume	59
dc.identifier.doi	10.1007/s10528-021-10068-5
dc.relation.issue	6
dc.relation.volume	59